Trial · NCT02257567
Adverse events4,598
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 4,598
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | LEUKOPENIA | Blood and lymphatic system disorders | Arm F (Phase II Expansion): Pola+BG in DLBCL | 0 | 20 | 0 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Arm G+H (Phase II NF Cohort): Pola+BR in DLBCL | 7 | 106 | 17 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in FL | 0 | 6 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in DLBCL | 0 | 6 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in FL | 0 | 6 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in DLBCL | 0 | 6 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm A (Phase II Randomization): Pola+BR in FL | 3 | 38 | 5 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm B (Phase II Randomization): BR in FL | 3 | 41 | 4 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm C (Phase II Randomization): Pola+BR in DLBCL | 0 | 39 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm D (Phase II Randomization): BR in DLBCL | 5 | 39 | 6 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm E (Phase II Expansion): Pola+BG in FL | 2 | 20 | 5 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm F (Phase II Expansion): Pola+BG in DLBCL | 0 | 20 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Arm G+H (Phase II NF Cohort): Pola+BR in DLBCL | 5 | 106 | 7 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in FL | 2 | 6 | 4 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in DLBCL | 0 | 6 | 0 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in FL | 2 | 6 | 8 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in DLBCL | 1 | 6 | 1 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Arm A (Phase II Randomization): Pola+BR in FL | 16 | 38 | 31 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Arm B (Phase II Randomization): BR in FL | 11 | 41 | 18 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Arm C (Phase II Randomization): Pola+BR in DLBCL | 14 | 39 | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02257567/events?page=2